Parametric Risk Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$3.37M Hold
104,967
0.23% 60
2016
Q2
$3.51M Buy
104,967
+83,887
+398% +$2.68M 0.23% 65
2016
Q1
$593K Hold
21,080
0.04% 116
2015
Q4
$646K Hold
21,080
0.04% 109
2015
Q3
$628K Hold
21,080
0.04% 111
2015
Q2
$671K Hold
21,080
0.04% 109
2015
Q1
$696K Hold
21,080
0.05% 112
2014
Q4
$623K Hold
21,080
0.04% 114
2014
Q3
$591K Hold
21,080
0.04% 123
2014
Q2
$594K Hold
21,080
0.04% 115
2014
Q1
$642K Buy
+21,080
New +$629K 0.04% 112
2013
Q4
Sell
-30,735
Closed -$838K 153
2013
Q3
$838K Hold
30,735
0.06% 89
2013
Q2
$817K Buy
+30,735
New +$849K 0.06% 84

Other funds holding PFE

Parametric Risk Advisors's PFE Position: Q3 2016 in Review

Parametric Risk Advisors held its Pfizer (PFE) position steady in Q3 2016 at 104,967 shares worth $3.37M. The position accounts for 0.23% of the portfolio, ranked #60.

Parametric Risk Advisors first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $3.51M in Q2 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Parametric Risk Advisors held 104,967 shares of Pfizer worth $3.37M as of Q3 2016.
  • Parametric Risk Advisors left its Pfizer share count unchanged in Q3 2016.
  • Pfizer made up 0.23% of Parametric Risk Advisors's portfolio in Q3 2016, its #60 holding.
  • Parametric Risk Advisors first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
  • Parametric Risk Advisors's Pfizer position peaked at $3.51M in Q2 2016.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Parametric Risk Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.